Progyny price target raised to $38 from $30 at Leerink
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Target $38; Price $32.24; Firm Leerink Partners; Analyst Michael Cherny.
Target: $38
Posted price: $32.24
Analyst firm: Leerink Partners
Analyst: Michael Cherny
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.